Worldcoin Launches Token Unlocking Program
Worldcoin (WLD) is set to launch a significant token unlocking program on July 24 that will gradually unlock 2.38 billion WLDs worth approximately $5.54 billion over the next four years.
According to these numbers, an average of 1.63 million WLDs will be unlocked daily.
In anticipation of this, Worldcoin has already transferred 990 million WLDs to an address beginning with the 0x2E3 designation and allocated an additional 494 million WLDs to 222 addresses. This strategic move is intended to facilitate a smooth transition once the unlock process begins.
Worldcoin ‘s tokenomics have recently faced criticism, particularly regarding its low float rate. Also, according to the information, Worldcoin has the lowest “float” ratio among the top 300 cryptocurrencies by market capitalization, amounting to 0.02.
READ MORE:
Bakkt може да улови значителен дял от обема на търговията с BTCThis ratio represents the ratio between a cryptocurrency’s market value and its fully diluted market value (FDV). Cryptocurrencies with low float ratios (market value/FDV ratios below 0.51) have a significant portion of the token supply not yet unlocked, which may lead to future volatility as unlocked tokens enter the market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.
